8YY.SI - Biolidics Limited

SES - SES Delayed Price. Currency in SGD
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
5,029
3,960
10,669
6,030
Total cash
5,029
3,960
10,669
6,030
Net receivables
515
126.842
201.741
223.923
Inventory
27
1,508
1,610
903.613
Total current assets
5,920
6,110
12,945
7,718
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
3,661
4,025
3,826
3,523
Accumulated depreciation
-3,493
-2,833
-2,419
-2,186
Net property, plant and equipment
168
1,193
1,407
1,337
Goodwill
0
625.983
625.983
-
Intangible assets
-
3,495
3,777
566.765
Total non-current assets
168
5,314
5,810
1,904
Total assets
6,088
11,424
18,755
9,622
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
1,050
1,021
869.337
-
Accounts payable
93
84.556
143.441
522.916
Other current liabilities
26
26.496
107.269
26.496
Total current liabilities
6,008
2,417
2,292
1,419
Non-current liabilities
Long-term debt
1,693
2,743
3,764
-
Deferred tax liabilities
0
476.275
532.862
-
Deferred revenues
-
-
0
34.88
Other long-term liabilities
-
3,214
3,507
-
Total non-current liabilities
1,768
6,675
8,191
436.649
Total liabilities
7,776
9,091
10,483
1,856
Stockholders' equity
Common stock
64,358
58,883
58,335
53,799
Retained earnings
-66,059
-56,685
-50,701
-46,050
Total stockholders' equity
-1,688
2,332
8,272
7,766
Total liabilities and stockholders' equity
6,088
11,424
18,755
9,622